Genitourinary Cancers

Although standard chemotherapy is often effective in the first-line treatment of locally invasive urothelial carcinoma, until recently, there have been few second- or third-line treatment options for patients with advanced or metastatic disease. Read More ›

Adjuvant Chemotherapy in Upper-Tract Urothelial Cancer Shows Impressive Gains in the POUT Trial

By Phoebe Starr

TON - May 2018, Vol 11, No 2

At the 2018 Genitourinary Cancers Symposium, lead investigator Alison Jane Birtle, MD, MBBS, MRCP, FRCR, presented the results of the phase 3 POUT clinical trial, which showed that adjuvant chemotherapy had impressive gains in the disease-free survival and metastasis-free survival in upper-tract urothelial cancer

By Phoebe Starr

Genitourinary Cancers

TON - May 2017, Vol 10, No 3

Androgen deprivation therapy (ADT) for the treatment of prostate cancer has adverse effects that may be difficult for men to tolerate. Read More ›

Monitoring for Bone Health

By Angela Hunter, BSN; Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Dianna Shafer talks about the testing protocol when examining patients’ bones and what they prescribe to ensure their patients’ bone health is being addressed. Read More ›

Treatment When Cancer Metastasizes

By Dianna Shafer, BSN, CURN, CPN, CPC-I; Pam Skurkay, RN, BSN, CPAN, CURN; Angela Hunter, BSN

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Dianna Shafer talks about when testing shows metastasis, and how they use Xgeva when a patient is in this state. Read More ›

Skeletal-Related Events for Bone Metastases

By Angela Hunter, BSN; Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the rates of incidences of this issue as well as the benefits of using Xgeva, including a better quality of life for patients. Read More ›

Patients with Metastatic Prostate Cancer

By Angela Hunter, BSN; Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Pam Skurkay discusses the comparison rate of skeletal related events in bisphosphonates versus Xgeva. Read More ›

Technology and Bone Health Therapies

By Angela Hunter, BSN; Dianna Shafer, BSN, CURN, CPN, CPC-I; Pam Skurkay, RN, BSN, CPAN, CURN

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Pam Skurkay, Dianna Shafer, and Angela Hunter talk about how technology and new medicines are not only helpful for patients, but assists researchers and providers in finding more information including locating clinical trials. Read More ›

Prescribing Patterns in Low Trauma Bone Fractures

By Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I; Angela Hunter, BSN

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Pam Skurkay, Dianna Shafer, and Angela Hunter talk about following patients taking bisphosphonates and those who take Xgeva. Read More ›

Factors Surrounding Use of Antiresportive Agents and Xgeva

By Pam Skurkay, RN, BSN, CPAN, CURN; Dianna Shafer, BSN, CURN, CPN, CPC-I; Angela Hunter, BSN

Genitourinary Cancers, Video

TON Interview with the Innovators: Volume 1

Pam Skurkay talks about when providers consider prescribing one class of drugs versus another with factors that include the patient's insurance and overall health. Read More ›

Genitourinary Cancers

View the Latest Issue of TON

Subscribe Today!

I'd like to receive:

Genitourinary Cancers

Page 1 of 6

View the Latest Issue of TON

Subscribe Today!

I'd like to receive: